Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1) → HCID 178502280, compound

HRID 1800771Notes

Reaction equation

HRID 1800771 reaction equation
[CH3:1][O:2][C:3]([NH:5][C@H:6]([C:8]([OH:10])=O)[CH3:7])=[O:4].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[CH2:35]1[C:39]2([O:44][CH2:43][CH2:42][CH2:41][O:40]2)[CH2:38][C@@H:37]([C:45]2[NH:46][CH:47]=[C:48]([C:50]3[CH:55]=[CH:54][C:53]([C:56]4[CH:61]=[CH:60][C:59]([C:62]5[N:63]=[C:64]([C@@H:67]6[CH2:71][CH2:70][CH2:69][N:68]6[C:72]([C@@H:74]([NH:78][C:79](=[O:82])[O:80][CH3:81])[CH:75]([CH3:77])[CH3:76])=[O:73])[NH:65][CH:66]=5)=[CH:58][CH:57]=4)=[CH:52][CH:51]=3)[N:49]=2)[NH:36]1>CN(C=O)C>[CH3:7][C@H:6]([NH:5][C:3](=[O:4])[O:2][CH3:1])[C:8]([N:36]1[C@H:37]([C:45]2[NH:46][CH:47]=[C:48]([C:50]3[CH:51]=[CH:52][C:53]([C:56]4[CH:61]=[CH:60][C:59]([C:62]5[N:63]=[C:64]([C@@H:67]6[CH2:71][CH2:70][CH2:69][N:68]6[C:72](=[O:73])[C@@H:74]([NH:78][C:79]([O:80][CH3:81])=[O:82])[CH:75]([CH3:77])[CH3:76])[NH:65][CH:66]=5)=[CH:58][CH:57]=4)=[CH:54][CH:55]=3)[N:49]=2)[CH2:38][C:39]2([O:44][CH2:43][CH2:42][CH2:41][O:40]2)[CH2:35]1)=[O:10]

Participants

5

Reactant 3

HCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 13048344N-carbomethoxy-L-alanineHCID 178502363HCID 178502363, compound

Product 1

HCID 178502280HCID 178502280, compoundYield 29%

Reagents, catalysts & solvents 1

HCID 6228DimethylformamideSolvent

Procedure

To a stirred solution of N-[(methyloxy)carbonyl]-L-alanine (22.5 mg, 0.153 mmol, prepared according to the procedure provided in WO2003055474) in DMF (2 mL) were added TEA (15.5 mg, 0.153 mmol) and HATU (58.2 mg, 0.153 mmol). After ˜3 min stirring, methyl [(1S)-1-({(2S)-2-[4-(4′-{2-[(3S)-6,10-dioxa-2-azaspiro[4.5]dec-3-yl]-1H-imidazol-4-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}carbonyl)-2-methylpropyl]carbamate (Example 19) (100 mg, 0.153 mmol) was introduced. After stirred for additional 2 hrs at rt, the reaction mixture was directly loaded to RP HPLC, eluting with 5 to 80% acetonitrile/water (0.2% NH3H2O(conc.)), to give methyl ((1S)-1-methyl-2-{(3S)-3-[4-(4′-{2-[(2S)-1-((2S)-3-methyl-2-{[(methyloxy)carbonyl]amino}butanoyl)-2-pyrrolidinyl]-1H-imidazol-4-yl}-4-biphenylyl)-1H-imidazol-2-yl]-6,10-dioxa-2-azaspiro[4.5]dec-2-yl}-2-oxoethyl)carbamate (Example 5) as solid (36 mg, yield: 29%). 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 10.04-11.11 (m, 2H) 7.37-8.02 (m, 8H) 7.18-7.36 (m, 2H) 5.60 (br. s., 2H) 5.17-5.40 (m, 2H) 3.17-4.73 (m, 14H) 2.79-3.19 (m, 1H) 2.45-2.81 (m, 1H) 2.29-2.45 (m, 1H) 1.49-2.29 (m, 8H) 1.22-1.47 (m, 3H) 0.73-1.16 (m, 6H). HRMS: (M+H)+ calcd: 783.3830; found: 783.3832.

Workup

  1. stirringAfter stirred for additional 2 hrs at rt
  2. washeluting with 5 to 80% acetonitrile/water (0.2% NH3H2O(conc.))

Sources & evidence

ORD record
ord-8727d84a442742c686086dab00aa1f08
Source dataset
uspto-grants-2013_01
Patent number
US08344155B2

Reaction notes

Loading…